![]() The oral solution of claim 8, wherein: the citric acid is present in an amount of about 10.5-15% weight/volume the magnesium hydroxide is present in an amount ranging from about 2-3% weight/volume and the oral solution further comprises: benzoic acid sodium saccharin and disodium EDTA.ġ0. The oral solution of claim 1, further comprising: at least one of a flavoring additive or a dye.ĩ. The oral solution of claim 1, further comprising: sodium saccharin in an amount of about 0.070% weight/volume.Ĩ. The oral solution of claim 1, further comprising: benzoic acid in an amount of from about 0.025-0.075 weight/volume.ħ. The oral solution of claim 1, wherein: said magnesium hydroxide is present in an amount of from about 2-3% weight/volume.Ħ. The oral solution of claim 1, wherein: said citric acid is present in an amount of about 10.9% weight/volume.ĥ. The oral solution of claim 1, wherein: said citric acid is present in an amount of about 10.5-15% weight/volume.Ĥ. The oral solution of claim 1, wherein: said citric acid is present in an amount of about 10.5-20% weight/volume.ģ. A magnesium citrate oral solution, comprising: citric acid in an amount greater than 10% weight/volume magnesium hydroxide in an amount ranging from about 1.5-5% weight/volume and water.Ģ. Method for fixing food ingredients on a magnesium salt substrateĬoncentrated magnesium hydroxide preparationsġ. Stable oral preparation of macrolide antibiotics and method for stabilizing the same Sodium-free salt substitute containing citrates and method for producing the same ![]() Method for increasing urinary excretion of electrolytesĭietary supplementation with potassium magnesium citrate Tasteless forms of basic drugs prepared by adsorption in situ Picosulfate-containing preparation for colonic evacuation
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |